SARS-CoV-2 May Become Resistant, Mutate After Sotrovimab Treatment
Patients who receive one of the few antibody treatments that works against the Omicron variant must be carefully monitored because, after the drug is infused, the virus may mutate and become resistant to it, researchers warn.
Reuters Health Information
source https://www.medscape.com/viewarticle/970180?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/970180?src=rss
Comments
Post a Comment